Saturday, July 3, 2021

Resveratrol Supplementation Reduces Pain and Inflammation in Knee Osteoarthritis Patients Treated with Meloxicam: A Randomized Placebo-Controlled Study - PubMed


Resveratrol, a polyphenolic compound, is a powerful antioxidant with remarkable anti-inflammatory properties. Inflammation and pain plays an important role in the pathogenesis of knee osteoarthritis (OA) and could cause tissue damage and morbidity. The aim of this study was to evaluate the anti-inflammatory and pain reduction activities of orally administered resveratrol in patients with knee OA. We carried out a 90-day pilot study to evaluate the ability of orally administered resveratrol, as an adjuvant with meloxicam, to decrease knee joint pain and biomarkers of inflammation in comparison with a placebo. One hundred ten men and women (45-75 years old) diagnosed with mild to moderate knee OA were treated with 15 mg per day meloxicam and either 500 mg per day resveratrol or placebo for 90 days in a double-blind, randomized control trial. Pain severity was evaluated at the beginning and at the end of treatment using Visual Analogue Scale-100 scores. Fasting blood was collected to determine serum interleukins 1β and 6, tumor necrosis factor-α, C-reactive protein, and complement proteins C3 and C4. The resveratrol-treated group experienced a time-dependent significant decrease in pain severity (P < .001). Serum levels of the biochemical markers were significantly reduced compared with the placebo-treated group (P < .01). These findings suggest that resveratrol may be an effective "add-on" option with meloxicam in the treatment of patients with mild to moderate knee OA.

Keywords: inflammatory markers; knee OA; knee pain; meloxicam; resveratrol.

Similar articles

Hussain SA, Marouf BH, Ali ZS, Ahmmad RS.Clin Interv Aging. 2018 Sep 5;13:1621-1630. doi: 10.2147/CIA.S172758. eCollection 2018.PMID: 30233159 Free PMC article. Clinical Trial.

Dehghani S, Alipoor E, Salimzadeh A, Yaseri M, Hosseini M, Feinle-Bisset C, Hosseinzadeh-Attar MJ.Phytomedicine. 2018 Sep 15;48:70-75. doi: 10.1016/j.phymed.2018.04.060. Epub 2018 May 9.PMID: 30195882 Clinical Trial.

Hussain SA, Jassim NA, Numan IT, Al-Khalifa II, Abdullah TA.Saudi Med J. 2009 Jan;30(1):98-103.PMID: 19139781 Clinical Trial.

Malek Mahdavi A, Mahdavi R, Kolahi S.J Am Coll Nutr. 2016 Sep-Oct;35(7):597-603. doi: 10.1080/07315724.2015.1068139. Epub 2016 Mar 2.PMID: 26933897 Clinical Trial.

Arjmandi BH, Ormsbee LT, Elam ML, Campbell SC, Rahnama N, Payton ME, Brummel-Smith K, Daggy BP.J Med Food. 2014 Jun;17(6):707-13. doi: 10.1089/jmf.2013.0010. Epub 2014 Mar 10.PMID: 24611484 Free PMC article. Clinical Trial.

See all similar articles

Cited by 5 articles

Hodgin KS, Donovan EK, Kekes-Szabo S, Lin JC, Feick J, Massey RL, Ness TJ, Younger JW.Int J Environ Res Public Health. 2021 Mar 3;18(5):2483. doi: 10.3390/ijerph18052483.PMID: 33802381 Free PMC article. Clinical Trial.

Sun S, Yan Z, Shui X, Qi W, Chen Y, Xu X, Hu Y, Guo W, Shang P.J Cell Mol Med. 2020 Nov;24(22):13104-13114. doi: 10.1111/jcmm.15915. Epub 2020 Oct 16.PMID: 33063931 Free PMC article.

Li XZ, Zhang SN.Chin Med. 2020 Aug 1;15:80. doi: 10.1186/s13020-020-00363-5. eCollection 2020.PMID: 32765641 Free PMC article. Review.

D'Adamo S, Cetrullo S, Panichi V, Mariani E, Flamigni F, Borzì RM.Cells. 2020 May 16;9(5):1232. doi: 10.3390/cells9051232.PMID: 32429348 Free PMC article. Review.

Deng Z, Li Y, Liu H, Xiao S, Li L, Tian J, Cheng C, Zhang G, Zhang F.Biosci Rep. 2019 May 10;39(5):BSR20190189. doi: 10.1042/BSR20190189. Print 2019 May 31.PMID: 30996115 Free PMC article. Review.

Related information

LinkOut - more resources

  • Full Text Sources

o    Atypon

  • Other Literature Sources

o    scite Smart Citations

  • Miscellaneous

o    NCI CPTAC Assay Portal